Acadian Asset Management LLC Roivant Sciences Ltd. Transaction History
Acadian Asset Management LLC
- $32.2 Billion
- Q3 2024
A detailed history of Acadian Asset Management LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Acadian Asset Management LLC holds 21,566 shares of ROIV stock, worth $255,125. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,566
Previous 8,510
153.42%
Holding current value
$255,125
Previous $89,000
178.65%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$780 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$778 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$640 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$493 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$418 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.33B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...